BioSpace News Archive

Ideal for Cell and Gene Therapy and COVID-19 research, BioStore IIIv provides improved thermal stability for stored materials, risk mitigation advantages and processes which are documented and repeatable [05-August-2020] CHELMSFORD, Mass. , Aug. 5, 2020 /PRNewswire/ -- Brooks Life Sciences , a division of Brooks Automation, today announced the immediate availabilit

Veracyte, Inc . (Nasdaq: VCYT) today announced the publication of new data demonstrating that the Percepta ® classifier significantly reduces invasive procedures in lung cancer diagnosis by classifying nearly 40 percent of patients as “low risk” when bronchoscopy is inconclusive. The findings, from a large, prospect

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that it established 50 acres of spring Camelina under contract with a grower in Montana in the second quarter of 2020.

USD 200 million low-interest, five-year term loan commitment from Sumitomo Dainippon Pharma to further support planned commercialization of relugolix across multiple indications Agreement with Sunovion Pharmaceuticals provides access to well-established commercial infrastructure currently utilized across multiple successful products BASEL, Switzerland, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men,

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2020. “Bellerophon has achieved significant clinical and regulatory progress advancing our development program for the INOpulse® inhaled nit

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:30 p.m. EDT. To access a live webcast of the fireside chat on the “Investor Relations” page of Entera’s website, please click here . A replay of the webcast will be archived on Entera’

Beckman Coulter announced new analysis from the pivotal study of its novel monocyte distribution width hematologic biomarker for sepsis detection.

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will present four posters with data relevant to its GB001 and GB002 programs at the American Thoracic Society 2020 Virtual Conference, which takes place from August 5 th through 8 th .

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that the first patient has been dosed in its Phase 2 idiopathic pulmonary fibrosis (IPF) and chronic cough clinical study of its re-purposed drug NP-120 (Ifenprodil). The patient was enrolled and dosed at the Waikato Hospital located in Hampton, New Ze